157 related articles for article (PubMed ID: 17272747)
1. Oral administration of tetrahydrobiopterin slows the progression of atherosclerosis in apolipoprotein E-knockout mice.
Hattori Y; Hattori S; Wang X; Satoh H; Nakanishi N; Kasai K
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):865-70. PubMed ID: 17272747
[TBL] [Abstract][Full Text] [Related]
2. Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice.
Alp NJ; McAteer MA; Khoo J; Choudhury RP; Channon KM
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):445-50. PubMed ID: 14707037
[TBL] [Abstract][Full Text] [Related]
3. A specific role for eNOS-derived reactive oxygen species in atherosclerosis progression.
Takaya T; Hirata K; Yamashita T; Shinohara M; Sasaki N; Inoue N; Yada T; Goto M; Fukatsu A; Hayashi T; Alp NJ; Channon KM; Yokoyama M; Kawashima S
Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1632-7. PubMed ID: 17463333
[TBL] [Abstract][Full Text] [Related]
4. Tetrahydrobiopterin supplementation reduces atherosclerosis and vascular inflammation in apolipoprotein E-knockout mice.
Schmidt TS; McNeill E; Douglas G; Crabtree MJ; Hale AB; Khoo J; O'Neill CA; Cheng A; Channon KM; Alp NJ
Clin Sci (Lond); 2010 May; 119(3):131-42. PubMed ID: 20337596
[TBL] [Abstract][Full Text] [Related]
5. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
[TBL] [Abstract][Full Text] [Related]
6. Impaired endothelial function may be due to decreased aortic tetrahydrobiopterin, assessed by a new flow-mediated vasodilation in vivo in hypercholesterolemic/atherogenic mice.
Tamura Y; Naemura A; Inoue A; Ijiri Y; Seki J; Yada T; Goto M; Shinohara M; Kawashima S; Giddings JC; Yamamoto J
Blood Coagul Fibrinolysis; 2009 Dec; 20(8):699-705. PubMed ID: 19741507
[TBL] [Abstract][Full Text] [Related]
7. Anti-LOX-1 rescues endothelial function in coronary arterioles in atherosclerotic ApoE knockout mice.
Xu X; Gao X; Potter BJ; Cao JM; Zhang C
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):871-7. PubMed ID: 17272755
[TBL] [Abstract][Full Text] [Related]
8. Dysfunction of endothelial nitric oxide synthase and atherosclerosis.
Kawashima S; Yokoyama M
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):998-1005. PubMed ID: 15001455
[TBL] [Abstract][Full Text] [Related]
9. Tetrahydrobiopterin prevents endothelial dysfunction and restores adiponectin levels in rats.
Wang X; Hattori Y; Satoh H; Iwata C; Banba N; Monden T; Uchida K; Kamikawa Y; Kasai K
Eur J Pharmacol; 2007 Jan; 555(1):48-53. PubMed ID: 17098227
[TBL] [Abstract][Full Text] [Related]
10. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
Custodis F; Baumhäkel M; Schlimmer N; List F; Gensch C; Böhm M; Laufs U
Circulation; 2008 May; 117(18):2377-87. PubMed ID: 18443241
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of tetrahydrobiopterin attenuates testicular damage by reducing nitric oxide synthase activity in a cryptorchid mouse model.
Kondo Y; Ishikawa T; Yamaguchi K; Yada T; Fujisawa M
J Androl; 2008; 29(2):153-63. PubMed ID: 17978343
[TBL] [Abstract][Full Text] [Related]
12. CCR2-mediated antiinflammatory effects of endothelial tetrahydrobiopterin inhibit vascular injury-induced accelerated atherosclerosis.
Ali ZA; Bursill CA; Douglas G; McNeill E; Papaspyridonos M; Tatham AL; Bendall JK; Akhtar AM; Alp NJ; Greaves DR; Channon KM
Circulation; 2008 Sep; 118(14 Suppl):S71-7. PubMed ID: 18824773
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease.
Schmidt TS; Alp NJ
Clin Sci (Lond); 2007 Jul; 113(2):47-63. PubMed ID: 17555404
[TBL] [Abstract][Full Text] [Related]
14. Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice.
Phan O; Ivanovski O; Nguyen-Khoa T; Mothu N; Angulo J; Westenfeld R; Ketteler M; Meert N; Maizel J; Nikolov IG; Vanholder R; Lacour B; Drüeke TB; Massy ZA
Circulation; 2005 Nov; 112(18):2875-82. PubMed ID: 16267260
[TBL] [Abstract][Full Text] [Related]
15. Effects of tetrahydrobiopterin on coronary vascular reactivity in atherosclerotic human coronary arteries.
Worthley MI; Kanani RS; Sun YH; Sun Y; Goodhart DM; Curtis MJ; Anderson TJ
Cardiovasc Res; 2007 Dec; 76(3):539-46. PubMed ID: 17689509
[TBL] [Abstract][Full Text] [Related]
16. Atherosclerosis and the protective role played by different proteins in apolipoprotein E-deficient mice.
Fabrizio Rodella L; Bonomini F; Rezzani R; Tengattini S; Hayek T; Aviram M; Keidar S; Coleman R; Bianchi R
Acta Histochem; 2007; 109(1):45-51. PubMed ID: 17046051
[TBL] [Abstract][Full Text] [Related]
17. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
Eto H; Miyata M; Shirasawa T; Akasaki Y; Hamada N; Nagaki A; Orihara K; Biro S; Tei C
Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539
[TBL] [Abstract][Full Text] [Related]
18. Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease.
Channon KM
Trends Cardiovasc Med; 2004 Nov; 14(8):323-7. PubMed ID: 15596110
[TBL] [Abstract][Full Text] [Related]
19. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet.
Mehta JL; Sanada N; Hu CP; Chen J; Dandapat A; Sugawara F; Satoh H; Inoue K; Kawase Y; Jishage K; Suzuki H; Takeya M; Schnackenberg L; Beger R; Hermonat PL; Thomas M; Sawamura T
Circ Res; 2007 Jun; 100(11):1634-42. PubMed ID: 17478727
[TBL] [Abstract][Full Text] [Related]
20. Intrauterine exposure to maternal atherosclerotic risk factors increases the susceptibility to atherosclerosis in adult life.
Alkemade FE; Gittenberger-de Groot AC; Schiel AE; VanMunsteren JC; Hogers B; van Vliet LS; Poelmann RE; Havekes LM; Willems van Dijk K; DeRuiter MC
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2228-35. PubMed ID: 17656671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
